Persistence as a Robust Indicator of Medication Adherence-Related Quality and Performance

Bibliographic Data

ID15497178
AuthorsEnrica Menditto (0000-0001-8633-5650, University of Naples Federico II, corresponding author), Caitríona Cahir (0000-0002-7137-5737, Royal College of Surgeons in Ireland), Sara Malo (0000-0003-3561-0610, Instituto de Investigación Sanitaria Aragón), Isabel Aguilar‐Palacio (0000-0001-7293-701X, Instituto de Investigación Sanitaria Aragón), Marta Almada (0000-0001-6575-1698, Universidade do Porto), Elı́sio Costa (0000-0003-1158-1480, Universidade do Porto), Anna Giardini (0000-0002-2845-347X, Istituti Clinici Scientifici Maugeri), María Gil‐Peinado (0000-0001-5593-1484), María Gil Peinado (Drug Information Centre and Pharmaceutical Care Department, Muy Ilustre Colegio Oficial de Farmacéuticos de Valencia (MICOF Valencia), 46003 Valencia, Spain), Mireia Massot Mesquida (0000-0003-3649-5167, Institut Català de la Salut), Sara Mucherino (0000-0003-3357-5655, University of Naples Federico II), Valentina Orlando (0000-0002-8209-8878, University of Naples Federico II), Carlos Luís Parra-Calderón (0000-0003-2609-575X, Instituto de Biomedicina de Sevilla), Enrique Pepiol Salom (0000-0003-2289-5776, Biomechanics Institute of Valencia), Przemysław Kardas (0000-0002-6078-2628, Medical University of Lodz), Bernard Vrijens (0000-0002-9090-1253, University of Liège)
Year2021
Volume18
Issue9
Pages4872-4872
Publication date2021-05-03
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueInternational Journal of Environmental Research and Public Health (JOURNAL)
Journal identifiersISSN: 1661-7827 • E-ISSN: 1660-4601
PublisherMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/ijerph18094872
PMID34063641
OpenAlexW3158303320
LanguageEN
References cited45

Medication adherence is a priority for health systems worldwide and is widely recognised as a key component of quality of care for disease management. Adherence-related indicators were rarely explicitly included in national health policy agendas. One barrier is the lack of standardised adherence terminology and of routine measures of adherence in clinical practice. This paper discusses the possibility of developing adherence-related performance indicators highlighting the value of measuring persistence as a robust indicator of quality of care. To standardise adherence and persistence-related terminology allowing for benchmarking of adherence strategies, the European Ascertaining Barriers for Compliance (ABC) project proposed a Taxonomy of Adherence in 2012 consisting of three components: initiation, implementation, discontinuation. Persistence, which immediately precedes discontinuation, is a key element of taxonomy, which could capture adherence chronology allowing the examination of patterns of medication-taking behaviour. Advances in eHealth and Information Communication Technology (ICT) could play a major role in providing necessary structures to develop persistence indicators. We propose measuring persistence as an informative and pragmatic measure of medication-taking behaviour. Our view is to develop quality and performance indicators of persistence, which requires investing in ICT solutions enabling healthcare providers to review complete information on patients' medication-taking patterns, as well as clinical and health outcomes

Benchmarking · Business · Concordance · Discontinuation · eHealth · Health care · Medication adherence · Performance indicator · Persistence (discontinuity · Political science · Psychiatry · Public health · Quality (philosophy · Terminology · HIV/AIDS Research and Interventions · Medication Adherence and Compliance · Medicine · Nursing · Pharmaceutical Practices and Patient Outcomes · Health Informatics · Marketing

Tools

Open DOIOpen Access